A detailed history of Pca Investment Advisory Services Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Pca Investment Advisory Services Inc. holds 2,332 shares of NVO stock, worth $250,993. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,332
Previous 2,330 0.09%
Holding current value
$250,993
Previous $332,000 16.57%
% of portfolio
0.13%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $238 - $290
2 Added 0.09%
2,332 $277,000
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $37,058 - $44,366
302 Added 14.89%
2,330 $332,000
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $102 - $135
-1 Reduced 0.05%
2,028 $260,000
Q4 2023

Feb 15, 2024

BUY
$87.78 - $105.45 $178,105 - $213,958
2,029 New
2,029 $209,000
Q2 2023

Aug 16, 2023

BUY
$155.98 - $172.65 $134,766 - $149,169
864 New
864 $140 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pca Investment Advisory Services Inc. Portfolio

Follow Pca Investment Advisory Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pca Investment Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pca Investment Advisory Services Inc. with notifications on news.